PDF
File
Kurs
-6,99%
Likviditet
27,0 MSEK
Kalender
| Est. tid* | ||
| 2025-10-22 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-18 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-08 | - | X-dag ordinarie utdelning BIOG B 1.95 SEK |
| 2025-05-08 | - | X-dag bonusutdelning BIOG B 4.95 |
| 2025-05-07 | - | Årsstämma |
| 2025-05-07 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-10-22 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-08 | - | X-dag bonusutdelning BIOG B 5 |
| 2024-05-08 | - | X-dag ordinarie utdelning BIOG B 1.90 SEK |
| 2024-05-07 | - | Årsstämma |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-07 | - | Bokslutskommuniké 2023 |
| 2023-10-20 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-21 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag bonusutdelning BIOG B 1.45 |
| 2023-05-08 | - | X-dag ordinarie utdelning BIOG B 1.45 SEK |
| 2023-05-05 | - | Årsstämma |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-03 | - | Bokslutskommuniké 2022 |
| 2022-10-21 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-22 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-18 | - | Split BIOG B 1:5 |
| 2022-05-09 | - | X-dag bonusutdelning BIOG B 11.29 |
| 2022-05-09 | - | X-dag ordinarie utdelning BIOG B 3.63 SEK |
| 2022-05-06 | - | Årsstämma |
| 2022-05-06 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-04 | - | Bokslutskommuniké 2021 |
| 2021-10-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-07 | - | X-dag ordinarie utdelning BIOG B 3.41 SEK |
| 2021-05-06 | - | Årsstämma |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-04 | - | Bokslutskommuniké 2020 |
| 2020-11-25 | - | Extra Bolagsstämma 2020 |
| 2020-10-23 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-13 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-08 | - | X-dag ordinarie utdelning BIOG B 3.75 SEK |
| 2020-05-07 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-06 | - | Bokslutskommuniké 2019 |
| 2019-10-23 | - | Kvartalsrapport 2019-Q3 |
| 2019-05-09 | - | X-dag bonusutdelning BIOG B 5.95 |
| 2019-05-09 | - | X-dag ordinarie utdelning BIOG B 4.05 SEK |
| 2019-02-07 | - | Bokslutskommuniké 2018 |
| 2018-10-24 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-17 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-26 | - | X-dag bonusutdelning BIOG B 4.69 |
| 2018-04-26 | - | X-dag ordinarie utdelning BIOG B 4.31 SEK |
| 2018-04-25 | - | Årsstämma |
| 2018-04-25 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-08 | - | Bokslutskommuniké 2017 |
| 2017-10-25 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-18 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-04 | - | X-dag bonusutdelning BIOG B 4.34 |
| 2017-05-04 | - | X-dag ordinarie utdelning BIOG B 3.16 SEK |
| 2017-05-03 | - | Årsstämma |
| 2017-05-03 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-10 | - | Bokslutskommuniké 2016 |
| 2016-10-25 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-11 | - | X-dag bonusutdelning BIOG B 1.97 |
| 2016-05-11 | - | X-dag ordinarie utdelning BIOG B 3.03 SEK |
| 2016-05-10 | - | Årsstämma |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-03-18 | - | Extra Bolagsstämma 2016 |
| 2016-02-12 | - | Bokslutskommuniké 2015 |
| 2015-10-23 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-18 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-08 | - | X-dag bonusutdelning BIOG B 1.54 |
| 2015-05-08 | - | X-dag ordinarie utdelning BIOG B 3.46 SEK |
| 2015-05-07 | - | Årsstämma |
| 2015-05-07 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-12 | - | Bokslutskommuniké 2014 |
| 2014-10-22 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-20 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-07 | - | X-dag bonusutdelning BIOG B 3.65 |
| 2014-05-07 | - | X-dag ordinarie utdelning BIOG B 3.35 SEK |
| 2014-05-06 | - | Årsstämma |
| 2014-05-06 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-12 | - | Bokslutskommuniké 2013 |
| 2013-10-23 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-22 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-29 | - | X-dag bonusutdelning BIOG B 5.85 |
| 2013-04-29 | - | X-dag ordinarie utdelning BIOG B 4.15 SEK |
| 2013-04-26 | - | Analytiker möte 2013 |
| 2013-04-26 | - | Årsstämma |
| 2013-04-26 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-08 | - | Bokslutskommuniké 2012 |
| 2012-10-23 | - | Analytiker möte 2012 |
| 2012-10-23 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-21 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-09 | - | X-dag ordinarie utdelning BIOG B 1.26 SEK |
| 2012-05-09 | - | X-dag bonusutdelning BIOG B 2.74 |
| 2012-05-08 | - | Årsstämma |
| 2012-05-08 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-10 | - | Bokslutskommuniké 2011 |
| 2011-11-17 | - | Kapitalmarknadsdag 2011 |
| 2011-10-25 | - | Kvartalsrapport 2011-Q3 |
| 2011-05-11 | - | X-dag bonusutdelning BIOG B 1.08 |
| 2011-05-11 | - | X-dag ordinarie utdelning BIOG B 0.92 SEK |
| 2011-05-10 | - | Årsstämma |
| 2011-05-10 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-11 | - | Bokslutskommuniké 2010 |
| 2010-10-27 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-17 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-07 | - | X-dag bonusutdelning BIOG B 0.6 |
| 2010-05-07 | - | X-dag ordinarie utdelning BIOG B 0.90 SEK |
| 2010-05-06 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-22 | - | Bokslutskommuniké 2009 |
| 2009-10-22 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-18 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-23 | - | X-dag ordinarie utdelning BIOG B 0.40 SEK |
| 2009-04-22 | - | Årsstämma |
| 2009-04-22 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
BioGaia Osfortis for bone health[(1)] and BioGaia Prodentis for the mouth[(2)] are now launched in Sweden. By this, BioGaia's entire adult health portfolio is now available on the domestic market.
"In line with our already communicated strategy to accelerate the roll-out of our products for adults, we are pleased to now be able to offer the entire adult health portfolio to Swedish consumers," says Isabelle Ducellier, CEO of BioGaia.
BioGaia Osfortis and BioGaia Prodentis - two new and innovative products
BioGaia Osfortis capsules contain the clinically tested and patented lactic acid bacterium L. reuteri ATCC PTA 6475 and vitamin D3 which helps to maintain a normal bone structure.
BioGaia Prodentis lozenges are successfully sold in around 40 countries worldwide. BioGaia Prodentis contains the patented lactic acid bacteria L. reuteri DSM 17938 and ATCC PTA 5289 and has been tested in more than 50 clinical studies.
Some of BioGaia's largest products are already on the Swedish market:- BioGaia Protectis capsules and chewable tablets are available in several pack sizes and product variants. The tablets are also available with 10 or 20 µg of vitamin D3 which contributes to the normal function of the immune system.
- BioGaia Gastrus chewable tablets with mandarin flavor.
All products are sold via apotea.se (https://www.apotea.se/biogaia) and MEDS.se (https://www.meds.se/biogaia/). In the future, the products will be available in more pharmacy chains, both online and in physical stores. Read more about BioGaia's products in Sweden at produkter.biogaia.se.
Latest press releases from BioGaia
30.11.2020 Number of shares and votes in BioGaia
25.11.2020 Extraordinary General Meeting of BioGaia
03.11.2020 Nominating Committee ahead of the BioGaia AGM 6 May 2021
[1)] Vitamin D contributes to the maintenance of normal bones.
[2)] Consumption of foods containing isomalt and sucralose instead of sugar contributes to the maintenance of tooth mineralisation.
This product should not be a substitute for a varied and balanced diet and healthy lifestyle.
Isabelle Ducellier, CEO: +46 8 555 293 00